ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Merus NV

Merus NV (2GH)

41.40
0.00
(0.00%)
Closed 06 December 8:00AM
Realtime Data

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
41.40
Bid
41.00
Offer
41.80
Volume
0.00
0.00 Day's Range 0.00
21.40 52 Week Range 58.50
Previous Close
41.40
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
127
Financial Volume
-
VWAP
-

2GH Latest News

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy Study

Merus Announces FDA Approval of BIZENGRI® (zenocutuzumab-zbco) for NRG1+ Pancreatic Adenocarcinoma and NRG1+ Non–Small Cell Lung Cancer (NSCLC) Based on Safety and Efficacy Data From the eNRGy...

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer

Merus and Partner Therapeutics Announce License Agreement for the U.S. Commercialization of Zenocutuzumab in NRG1 Fusion-Positive Cancer UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02...

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive

Merus et Partner Therapeutics annoncent un contrat de licence en vue de la commercialisation aux États-Unis du zenocutuzumab dans le cadre du traitement des cancers à fusion NRG1 positive UTRECHT...

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt

Merus und Partner Therapeutics geben Lizenzvereinbarung für die Vermarktung von Zenocutuzumab in den USA bei NRG1-fusionspositivem Krebs bekannt UTRECHT, Niederlande, und CAMBRIDGE, Massachusetts...

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit Petosemtamab bekannt

Merus gibt am ESMO-Kongress 2024 in Asien die Veröffentlichung eines Abstracts zur Behandlung von rezidivierenden/metastasierten Kopf- und Halstumoren ab der zweiten Behandlungslinie mit...

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia

Merus annonce la publication d’un résumé sur le pétosemtamab en tant que traitement de 2e ligne et au-delà pour le CETC r/m lors de l’édition 2024 du Congrès de l’ESMO Asia – Les données...

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024

Merus Announces Publication of an Abstract on Petosemtamab as 2L+ treatment of r/m HNSCC at the ESMO Asia Congress 2024 – Petosemtamab 1500 mg monotherapy phase 2 interim data continues to...

Merus annonce sa participation aux prochaines journées Investisseurs

Merus annonce sa participation aux prochaines journées Investisseurs UTRECHT, Pays-Bas et CAMBRIDGE, État du Massachusetts, 07 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), une...

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen

Merus hält Vorträge auf bevorstehenden Investorenkonferenzen UTRECHT, Niederlande und CAMBRIDGE, Massachusetts, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), ein Unternehmen aus...

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab

La FDA octroie à Merus un report de la date PDUFA pour le zénocutuzumab UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 nov. 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS), ci-après...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.8-4.1666666666743.2474319244.19451697DE
4-8.6-17.25051.540.411744.74603537DE
12-3.8-8.4070796460245.251.540.412747.17167127DE
26-6.8-14.107883817448.257.540.415948.57608533DE
5218.4802358.521.39999917344.34418355DE
15617.673.949579831923.858.51916742.00023485DE
26017.673.949579831923.858.51916742.00023485DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
013CJDcom Inc
17.196 €
(0.00%)
0
013AJD.com Inc
34.40 €
(0.00%)
0
0110Thesis Gold Inc
0.412 €
(0.00%)
0
00WAspermont Ltd
0.0035 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0
013CJDcom Inc
17.196 €
(0.00%)
0
013AJD.com Inc
34.40 €
(0.00%)
0
0110Thesis Gold Inc
0.412 €
(0.00%)
0
00WAspermont Ltd
0.0035 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0
013CJDcom Inc
17.196 €
(0.00%)
0
013AJD.com Inc
34.40 €
(0.00%)
0
0110Thesis Gold Inc
0.412 €
(0.00%)
0
00WAspermont Ltd
0.0035 €
(0.00%)
0
000Greenvolt Energias Renovaveis SA
0.00 €
(0.00%)
0

Discussion

View Full Feed
ducci1 ducci1 8 minutes ago
Pivot Calcs: SPX Pivot--6080----R1--6088----R2--6102----S1--6066----S2--6058-----SPY Pivot--606----R1--607----R2--608----S1--605----S2--604-----VIX Pivot--13.62 !!LOL!!
SPY
PatentGuy1 PatentGuy1 10 minutes ago
Yes Apple invested $20 million, but put it into perspective. The $20 million Apple invested was change found in Apple’s figurative couch - chump change. Apple reportedly spent $10 Billion on project Titan, and walked away from EV. If/when Apple walks away from Liquidmetal, no one at Apple is goin
LQMT
eur06 eur06 12 minutes ago
I agree dino, regardless of this type of price action it’s a buy for me also.
VCNX
VCNX
IronPantz IronPantz 17 minutes ago
I happened to get back in a few months back at so I'm pretty happy now. The bag holders, I think are so wiped out it would take way more than a 10 bagger to get back to even. $7.00 to .0001. LOL I don't even know what the math on that is. But I do know what the math was on .0002 to $1.94. It won't d
DTGoody DTGoody 18 minutes ago
RespireRx collaborating with University College London to study treatment options for GRIA disorders:

https://youtu.be/iCofZjrUVzQ
RSPI
Vexari Vexari 22 minutes ago
Enforcement of law means

A Republic

If it can

Be kept
sentiment_stocks sentiment_stocks 26 minutes ago
These days, I don’t know if anything will surprise me anymore. And what you layout here, unfortunately, wouldn’t surprise me.

Let’s hope it’s just a coincidence.
NWBO
igotthemojo igotthemojo 26 minutes ago
i wont take offense since im only half nuts...
KBLB
Golden Cross Golden Cross 27 minutes ago
$ILLR Triller has what it takes to dominate social media in light of the upcoming TikTok ban.
https://www.foxbusiness.com/video/6351757905112
ILLR
bigsur25 bigsur25 27 minutes ago
MONI is a holding company look who is part of the holdings
MONI
Golden Cross Golden Cross 29 minutes ago
$ILLR Triller is the American answer to TikTok woes - Poll reveals majority of Americans view TikTok as a tool of Chinese influence ~ Ruling soon on TikTok ban.
http://toi.in/r8FNua60/a24gk
ILLR
manibiotech manibiotech 29 minutes ago
From diluting ... you mean?
NWBO
go seek go seek 29 minutes ago
No clue… meaningless IMO. Ok… Above my break-even price ;)
ENTA
Spuds McKenz66 Spuds McKenz66 34 minutes ago
rock and roll flaw ,

When the Share Consolidation becomes effective, every 20 share of the Company’s issued and outstanding Ordinary Shares will be combined into 1 issued and outstanding Ordinary Share. This will reduce the number of outstanding Class A Ordinary Shares from 199,456,
MLGO
powerbattles powerbattles 34 minutes ago
They need the record date, and, in this case, they don't have the exact date of the record date.
Dividend Structure: One additional share of common stock for each share owned as of the record date.
Record Date: Projected for the second week of January 2025
Payment Date: Within
BDPTD
Hitman970 Hitman970 36 minutes ago
75$
QUBT
IBB-99 IBB-99 41 minutes ago
LWLG on LinkedIn: https://www.linkedin.com/search/results/all/?keywords=lwlg&origin=GLOBAL_SEARCH_HEADER&sid=DUv
LWLG
GO4AWILDRIDE GO4AWILDRIDE 42 minutes ago
Israel Vazquez, three-time world champion boxer, dies at 46.

https://www.espn.com/boxing/story/_/id/42753781/israel-vazquez-three-world-champion-boxer-dies-46


GO4AWILDRIDE
StockItOut StockItOut 48 minutes ago
You keep saying new all time lows, yet F&F were in at 0.003. Meitze (I think it was) said he was in at 0.005.
XERI
kittycattttt kittycattttt 49 minutes ago
Wow which way will it go….. 📈
DOGEUSD
StockItOut StockItOut 51 minutes ago
You may want to try PM. You make it everyone's business otherwise. Classic maganut / slanted logic. such regularity in evading the evident, facts, truth, etc. must be the maga prunes.
XERI
boston127 boston127 52 minutes ago
You post here everyday.

How could you not watch this everyday?
IGPK

Your Recent History

Delayed Upgrade Clock